The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both

American Journal of Ophthalmology

Volumn 166, Issue , 2016, Pages ix-xi

  Browning, David J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; ANTIRHEUMATIC AGENT;

ACTUAL BODY WEIGHT; AUTOFLUORESCENCE; BODY WEIGHT; EDITORIAL; ELECTRORETINOGRAPHY; HUMAN; HYDROXYCHLOROQUINE RETINOPATHY; IDEAL BODY WEIGHT; OPHTHALMOLOGIST; PERIMETRY; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL FIELD; ADVERSE DRUG REACTION; CHEMICALLY INDUCED; DRUG EFFECT; PHYSICIAN ATTITUDE; RETINA; RETINA DISEASE; VISUAL SYSTEM EXAMINATION;

ANTIRHEUMATIC AGENTS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ELECTRORETINOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; OPHTHALMOLOGISTS; PHYSICIAN'S ROLE; PREVALENCE; RETINA; RETINAL DISEASES; VISUAL FIELDS;

EID: 84964619847     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2016.03.044     Document Type: Editorial

References (16)

1. A.H. Mackenzie Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials Am J Med 75 1A 1983 40 45
2. I. Mavrikakis, P.P. Sfikakis, E. Mavrikakis, and et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine - a reappraisal Ophthalmology 110 7 2003 1321 1326
3. F. Wolfe, and M.F. Marmor Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus Arthritis Care Res 62 6 2010 775 784
4. R.B. Melles, and M.F. Marmor The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy Arch Ophthalmol 132 12 2014 1453 1460
5. C. Cukras, N. Huynh, S. Vitale, W.T. Wong, F.L. Ferris III, and P.A. Sieving Subjective and objective screening tests for hydroxychloroquine toxicity Ophthalmology 122 2 2015 356 366
6. D.J. Browning, and C. Lee The relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy Clin Ophthalmol 8 2014 1389 1399
7. J.F. Jekel, J.G. Elmore, and D.L. Katz Epidemiology, Biostatistics, and Preventive Medicine 1996 WB Saunders Philadelphia 216 217
8. D.J. Browning Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice Am J Ophthalmol 155 3 2013 418 428
9. M.G. Lee, S.J. Kim, D.I. Ham, and et al. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy Invest Ophthalmol Vis Sci 56 1 2015 396 402
10. A. Fielder, E. Graham, S. Jones, A. Silman, and A. Tullo Royal College of Ophthalmologists guidelines: ocular toxicity and hydroxychloroquine Eye 12 Part 6 1998 907 909
11. D.J. Browning Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity Am J Ophthalmol 133 5 2002 649 656
12. P.M. Falcone, L. Paolini, and P.L. Lou Hydroxychloroquine toxicity despite normal dose therapy Ann Ophthalmol 25 10 1993 385 388
13. D.J. Browning Hydroxychloroquine and chloroquine retinopathy 2014 Springer New York
14. E.W. Mcchesney Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate Am J Med 75 1A 1983 11 18
15. D.J. Browning, C. Lee, and D. Rotberg The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women Clin Ophthalmol 8 2014 1401 1407
16. P.H. Blomquist, and R.K. Chundru Screening for hydroxychloroquine toxicity by Texas ophthalmologists J Rheumatol 29 8 2002 1665 1670